LINC00877 is a potential prognostic biomarker with functional significance in prostate cancer

Abstract To analyze the expression and clinical significance of LINC00877 in prostate cancer based on The Cancer Genome Atlas (TCGA) database and its relationship with immune infiltrates. The differential expression of LINC00877 and its association with clinical prognosis in prostate cancer were analyzed using TCGA datasets and validated with independent Gene Expression Omnibus (GEO) datasets. Gene Expression Profiling Interactive Analysis (GEPIA) was utilized to analyze overall survival (OS). Gene set enrichment analysis (GSEA) and single‐sample GSEA (ssGSEA) were conducted to analyze the correlation between LINC00877 and immune infiltrates. Gene Ontology (GO) function enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were used to analyze the related functions and pathway enrichment of differentially expressed genes. Furthermore, siRNA‐mediated knockdown of LINC00877 in prostate cancer cell lines was conducted to investigate the effects of LINC00877 on invasive capacity and cell cycle progression. LINC00877 was underexpressed in prostate cancer patients and associated with T stage and Gleason score. OS analysis revealed that prostate cancer patients with low expression of LINC00877 demonstrated worse prognosis. GSEA results showed that inflammatory response, KRAS, apoptosis, and the IL2/STAT5 signaling pathway were differentially enriched in prostate cancer samples. The KEGG and GO enrichment analysis showed that LINC00877 expression was found to be closely related to immune pathways. ssGSEA analysis found that LINC00877 expression correlated with the expression of tumor immune lymphocytes and immune checkpoint inhibitors. Knockdown of LINC00877 significantly promoted cell proliferation, enhanced invasion ability, and increased the S‐phase cell population in prostate cancer cells. LINC00877 serves as a potential prognostic biomarker and is implicated in tumor immunity. Functionally, siRNA‐mediated knockdown of LINC00877 in prostate cancer cells significantly promoted proliferation, enhanced invasion, and increased S‐phase cell cycle entry, suggesting an oncogenic role for LINC00877.

Authors

Institutions

Publication Details

Journal
Precision Medical Sciences
Published
2026-11-16
DOI
https://doi.org/10.1002/prm2.70051
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

LINC00877 is a potential prognostic biomarker with functional significance in prostate cancer

Xingbo Wang, Jingyuan Tang, Chen Zhu, Yan Xu et al.
Precision Medical Sciences
Cancer-related molecular mechanisms research
article

LINC00877 is a potential prognostic biomarker with functional significance in prostate cancer

Xingbo Wang, Jingyuan Tang, Chen Zhu, Yan Xu, Long Ma
article en

Abstract

Abstract To analyze the expression and clinical significance of LINC00877 in prostate cancer based on The Cancer Genome Atlas (TCGA) database and its relationship with immune infiltrates. The differential expression of LINC00877 and its association with clinical prognosis in prostate cancer were analyzed using TCGA datasets and validated with independent Gene Expression Omnibus (GEO) datasets. Gene Expression Profiling Interactive Analysis (GEPIA) was utilized to analyze overall survival (OS). Gene set enrichment analysis (GSEA) and single‐sample GSEA (ssGSEA) were conducted to analyze the correlation between LINC00877 and immune infiltrates. Gene Ontology (GO) function enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were used to analyze the related functions and pathway enrichment of differentially expressed genes. Furthermore, siRNA‐mediated knockdown of LINC00877 in prostate cancer cell lines was conducted to investigate the effects of LINC00877 on invasive capacity and cell cycle progression. LINC00877 was underexpressed in prostate cancer patients and associated with T stage and Gleason score. OS analysis revealed that prostate cancer patients with low expression of LINC00877 demonstrated worse prognosis. GSEA results showed that inflammatory response, KRAS, apoptosis, and the IL2/STAT5 signaling pathway were differentially enriched in prostate cancer samples. The KEGG and GO enrichment analysis showed that LINC00877 expression was found to be closely related to immune pathways. ssGSEA analysis found that LINC00877 expression correlated with the expression of tumor immune lymphocytes and immune checkpoint inhibitors. Knockdown of LINC00877 significantly promoted cell proliferation, enhanced invasion ability, and increased the S‐phase cell population in prostate cancer cells. LINC00877 serves as a potential prognostic biomarker and is implicated in tumor immunity. Functionally, siRNA‐mediated knockdown of LINC00877 in prostate cancer cells significantly promoted proliferation, enhanced invasion, and increased S‐phase cell cycle entry, suggesting an oncogenic role for LINC00877.

Precision Medical Sciences
Nanjing University of Chinese Medicine (CN)
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon